Development of an innovative dual nano-anticancer target system / Professor Ha-rin Kim (Department of Applied Chemistry)
- 25.03.31 / 이정민
A research team led by Professor Ha-Rin Kim of the Department of Biomedical Sciences, College of Science and Technology, Kookmin University (President Jung Seung-ryul) has developed a new concept of dual nano-targeted anticancer system that can more precisely and effectively attack cancer cells. This study was conducted in collaboration with Professor Park Joo-ho's research team (Magain, Lim Hansol) at the Department of Biomedical Sciences at Konkuk University's Global Campus, and it presented a new anticancer treatment strategy using sophisticated interactions between nanoparticles.
Professor Kim's research team designed two types of anticancer nanoparticles with complementary functions. The difference is that the “dual attack mechanism” is implemented in which the first nanoparticle acts on cancer cells first, and then the second nanoparticle binds to it to carry out additional attacks. This system is characterized by not only inducing simple cell death, but also activating the immune response to induce a more powerful therapeutic effect.
Professor Ha-Rin Kim said, “This study has presented a new possibility to overcome the limitations of existing treatments by activating immune cells and inducing the death of cancer cells through a precise targeting system between nanoparticles,” and “We will continue to focus on developing precise targeted treatment technologies that can be applied to various cancers.”
Co-first author Ma Ga-eun and Lim Han-sol said, “This research presents a new paradigm for anticancer treatment by utilizing the unique physical and chemical properties of nanomaterials,” and “We hope that this achievement will make a meaningful contribution to the development of next-generation anticancer treatment strategies.”
The research results were published in Nano Today (IF 17.4), a prestigious international journal in the field of nanotechnology, and the research team was honored to be selected for the 'People Who Shined Korea (Hanbitsa)' by the Biological Research Information Center (BRIC).
Meanwhile, this research was conducted with the support of research funding from the National Research Foundation of Korea, the BK21 project, and other research grants. Kookmin University plans to continue its leading research in the field of biomedicine to strengthen its world-class research capabilities.
|
This content is translated from Korean to English using the AI translation service DeepL and may contain translation errors such as jargon/pronouns. If you find any, please send your feedback to kookminpr@kookmin.ac.kr so we can correct them.
|
|
Development of an innovative dual nano-anticancer target system / Professor Ha-rin Kim (Department of Applied Chemistry) |
||||
|---|---|---|---|---|
|
2025-03-31
44
A research team led by Professor Ha-Rin Kim of the Department of Biomedical Sciences, College of Science and Technology, Kookmin University (President Jung Seung-ryul) has developed a new concept of dual nano-targeted anticancer system that can more precisely and effectively attack cancer cells. This study was conducted in collaboration with Professor Park Joo-ho's research team (Magain, Lim Hansol) at the Department of Biomedical Sciences at Konkuk University's Global Campus, and it presented a new anticancer treatment strategy using sophisticated interactions between nanoparticles.
Professor Kim's research team designed two types of anticancer nanoparticles with complementary functions. The difference is that the “dual attack mechanism” is implemented in which the first nanoparticle acts on cancer cells first, and then the second nanoparticle binds to it to carry out additional attacks. This system is characterized by not only inducing simple cell death, but also activating the immune response to induce a more powerful therapeutic effect.
Professor Ha-Rin Kim said, “This study has presented a new possibility to overcome the limitations of existing treatments by activating immune cells and inducing the death of cancer cells through a precise targeting system between nanoparticles,” and “We will continue to focus on developing precise targeted treatment technologies that can be applied to various cancers.”
Co-first author Ma Ga-eun and Lim Han-sol said, “This research presents a new paradigm for anticancer treatment by utilizing the unique physical and chemical properties of nanomaterials,” and “We hope that this achievement will make a meaningful contribution to the development of next-generation anticancer treatment strategies.”
The research results were published in Nano Today (IF 17.4), a prestigious international journal in the field of nanotechnology, and the research team was honored to be selected for the 'People Who Shined Korea (Hanbitsa)' by the Biological Research Information Center (BRIC).
Meanwhile, this research was conducted with the support of research funding from the National Research Foundation of Korea, the BK21 project, and other research grants. Kookmin University plans to continue its leading research in the field of biomedicine to strengthen its world-class research capabilities.
|
||||
